# FDA Inspection 969894 - Octapharma Plasma, Inc. - May 26, 2016

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/22b05bfd-275d-43c4-a085-36e091a09b66
Source feed: FDA_Inspections

> FDA Inspection 969894 for Octapharma Plasma, Inc. on May 26, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 969894
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2016-05-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1105240 - 2019-08-28](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1263d787-c7ae-4a24-a90f-67ead87b34b6)
- [FDA Inspection 907990 - 2014-12-15](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0a789f1b-739f-4ee6-b335-377831441df3)
- [FDA Inspection 755675 - 2011-11-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bc4f8fc1-c84a-4995-b111-3a1fca82e92a)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/89f07fa8-6ebc-45c7-808c-0bda084c01df

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d